<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><description>药渡以自有药物大数据为依托，对上市及临床在研药物、药物研究进展和重要药物市场商业动态作出信息整合分析，传递药物创新一手资讯</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 06 May 2021 10:09:01 +0800</pubDate><image><url>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</url><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>共价结合药物的设计与开发</title><link>https://mp.weixin.qq.com/s/fUkrw8udcEqgN-9ip3yEdw</link><description></description><content:encoded><![CDATA[共价结合药物的设计与开发]]></content:encoded><pubDate>Wed, 05 May 2021 21:40:55 +0800</pubDate></item><item><title>药明康德研发PD-L1小分子抑制剂</title><link>https://mp.weixin.qq.com/s/8MKsxWT83s41IUyPFWKZFA</link><description></description><content:encoded><![CDATA[药明康德研发PD-L1小分子抑制剂]]></content:encoded><pubDate>Wed, 05 May 2021 21:40:55 +0800</pubDate></item><item><title>【5月14日，线上直播】肝病新药研发的挑战和机遇</title><link>https://mp.weixin.qq.com/s/lwri0bOFnR75FBLvSlbASA</link><description></description><content:encoded><![CDATA[【5月14日，线上直播】肝病新药研发的挑战和机遇]]></content:encoded><pubDate>Wed, 05 May 2021 21:40:55 +0800</pubDate></item><item><title>重磅！汇恩兰德为您提供全方位的CDMO服务</title><link>https://mp.weixin.qq.com/s/N_AtLfL2VD0sXvKz1OJIAw</link><description></description><content:encoded><![CDATA[重磅！汇恩兰德为您提供全方位的CDMO服务]]></content:encoded><pubDate>Wed, 05 May 2021 21:40:55 +0800</pubDate></item><item><title>好书推荐 | 《化学试剂•化学药品手册》</title><link>https://mp.weixin.qq.com/s/2aXWA8KjH7s7_oqIlX5gfQ</link><description></description><content:encoded><![CDATA[好书推荐 | 《化学试剂•化学药品手册》]]></content:encoded><pubDate>Wed, 05 May 2021 21:40:55 +0800</pubDate></item><item><title>药渡招聘 | 咨询合伙人</title><link>https://mp.weixin.qq.com/s/TKy11shDOVBp1mPo-08Axg</link><description></description><content:encoded><![CDATA[药渡招聘 | 咨询合伙人]]></content:encoded><pubDate>Wed, 05 May 2021 21:40:55 +0800</pubDate></item><item><title>【一病一图】子宫内膜癌的临床用药竞争格局(2021.4)</title><link>https://mp.weixin.qq.com/s/SEbf6PkNRx4kSQQhE8n6Mw</link><description></description><content:encoded><![CDATA[【一病一图】子宫内膜癌的临床用药竞争格局(2021.4)]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>厦门大学报道三阴性乳腺癌的一种潜在治疗策略：EGFR CAR-T联合CDK7-TKI</title><link>https://mp.weixin.qq.com/s/zQFo0i5n5KHunf6fChS0KA</link><description></description><content:encoded><![CDATA[厦门大学报道三阴性乳腺癌的一种潜在治疗策略：EGFR CAR-T联合CDK7-TKI]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>劳动最光荣 | 记录劳动瞬间，领取现金大奖</title><link>https://mp.weixin.qq.com/s/O9Ka6ROVpKcAXE36lSSsOg</link><description></description><content:encoded><![CDATA[劳动最光荣 | 记录劳动瞬间，领取现金大奖]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>【5月11日，线上直播】非小细胞肺癌影像学疗效评估及进展</title><link>https://mp.weixin.qq.com/s/BYWVdOpGHHca5w_VHdCT_A</link><description></description><content:encoded><![CDATA[【5月11日，线上直播】非小细胞肺癌影像学疗效评估及进展]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>好书推荐 |《新药化学全合成路线手册》</title><link>https://mp.weixin.qq.com/s/vjchq9bSXAf3yLZlqc7DAw</link><description></description><content:encoded><![CDATA[好书推荐 |《新药化学全合成路线手册》]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>有偿投稿 | 让你的知识创造更大的价值！</title><link>https://mp.weixin.qq.com/s/D30GkxCayjimJy8m7RU2ow</link><description></description><content:encoded><![CDATA[有偿投稿 | 让你的知识创造更大的价值！]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>【一图一药】从Dostarlimab看PD-1抗体的竞争格局</title><link>https://mp.weixin.qq.com/s/qWwYGIwZN7QwXdN-2nuosg</link><description></description><content:encoded><![CDATA[【一图一药】从Dostarlimab看PD-1抗体的竞争格局]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>Cell Rep：基于类器官的高通量RNA测序有助于寻找治疗结直肠癌的药物</title><link>https://mp.weixin.qq.com/s/ZoFFYIBdkRO7UWL-y9nWHQ</link><description></description><content:encoded><![CDATA[Cell Rep：基于类器官的高通量RNA测序有助于寻找治疗结直肠癌的药物]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>劳动最光荣 | 记录劳动瞬间，领取现金大奖</title><link>https://mp.weixin.qq.com/s/wAFHWI6RGa_xTKvnMpGslQ</link><description></description><content:encoded><![CDATA[劳动最光荣 | 记录劳动瞬间，领取现金大奖]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>【5月14日，线上直播】肝病新药研发的挑战和机遇</title><link>https://mp.weixin.qq.com/s/SiILjcHnZLXrSbEJNaCBgA</link><description></description><content:encoded><![CDATA[【5月14日，线上直播】肝病新药研发的挑战和机遇]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>好书推荐 |《药物结构优化设计策略和经验规则》</title><link>https://mp.weixin.qq.com/s/mOVxkfkCXLYSBlshPc9CMA</link><description></description><content:encoded><![CDATA[好书推荐 |《药物结构优化设计策略和经验规则》]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>有偿投稿 | 让你的知识创造更大的价值！</title><link>https://mp.weixin.qq.com/s/7C6RCBExVXGcen9AkAvb6g</link><description></description><content:encoded><![CDATA[有偿投稿 | 让你的知识创造更大的价值！]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>欢度五一！劳动你我最光荣！</title><link>https://mp.weixin.qq.com/s/8KY0wQpYi_S78EMTrzkcKg</link><description></description><content:encoded><![CDATA[欢度五一！劳动你我最光荣！]]></content:encoded><pubDate>Fri, 30 Apr 2021 17:48:41 +0800</pubDate></item><item><title>劳动最光荣 | 记录劳动瞬间，领取现金大奖</title><link>https://mp.weixin.qq.com/s/bPunpoXdHwfc0bAsWsHEHA</link><description></description><content:encoded><![CDATA[劳动最光荣 | 记录劳动瞬间，领取现金大奖]]></content:encoded><pubDate>Fri, 30 Apr 2021 17:48:41 +0800</pubDate></item></channel></rss>